Fidelity Investments’s Turnstone Biologics TSBX Stock Holding History

Fidelity Investments’s Portfolio TSBX Stock Details TSBX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-1,133,987	Closed	-$407K	–	5586
2025 Q2	$407K	Hold	1,133,987	–	–	﹤0.01%	3042
2025 Q1	$465K	Sell	1,133,987 -50,056	-4%	-$21.3K	﹤0.01%	2925
2024 Q4	$586K	Buy	1,184,043 +11,056	+0.9%	+$5.46K	﹤0.01%	2863
2024 Q3	$653K	Buy	1,172,987 +37,738	+3%	+$57.9K	﹤0.01%	2751
2024 Q2	$2.97M	Sell	1,135,249 -439,577	-28%	-$1.26M	﹤0.01%	2238
2024 Q1	$4.13M	Sell	1,574,826 -971,835	-38%	-$2.78M	﹤0.01%	2127
2023 Q4	$6.48M	Sell	2,546,661 -283,623	-10%	-$740K	﹤0.01%	1980
2023 Q3	$11.2M	Buy	+2,830,284	New	+$25.2M	﹤0.01%	1797

Fidelity Investments's TSBX Position: Q3 2025 in Review

Fidelity Investments sold out of Turnstone Biologics (TSBX) in Q3 2025, closing a stake of 1,133,987 shares — an estimated $407K sold.

Fidelity Investments first reported a position in TSBX in Q3 2023 and held it in 8 quarters. The position peaked at $11.2M in Q3 2023. 1 fund tracked by Wall St. Rank holds TSBX as of Q3 2025.

Fidelity Investments reported no remaining Turnstone Biologics position as of Q3 2025 after selling out during the quarter.
Fidelity Investments sold 1,133,987 Turnstone Biologics shares in Q3 2025, an estimated $407K.
Fidelity Investments first reported a position in Turnstone Biologics in Q3 2023 and held it in 8 quarters.
Fidelity Investments's Turnstone Biologics position peaked at $11.2M in Q3 2023.
1 fund tracked by Wall St. Rank held Turnstone Biologics as of Q3 2025.

Based on Fidelity Investments's 13F filing for Q3 2025, filed 13 Nov 2025.